BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25776482)

  • 1. Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancer.
    Yao S; Zhao T; Jin H
    Biomed Pharmacother; 2015 Mar; 70():72-9. PubMed ID: 25776482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
    Xiao P; Liu WL
    Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1.
    Li H; Huang W; Luo R
    Diagn Pathol; 2015 Jul; 10():117. PubMed ID: 26194496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.
    Sun C; Li S; Yang C; Xi Y; Wang L; Zhang F; Li D
    Biochem Biophys Res Commun; 2016 Feb; 471(1):82-8. PubMed ID: 26845350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-142-3p Overexpression Increases Chemo-Sensitivity of NSCLC by Inhibiting HMGB1-Mediated Autophagy.
    Chen Y; Zhou X; Qiao J; Bao A
    Cell Physiol Biochem; 2017; 41(4):1370-1382. PubMed ID: 28427045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer.
    Zhang C; Ge S; Hu C; Yang N; Zhang J
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1055-61. PubMed ID: 24247270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.
    Liu PL; Liu WL; Chang JM; Chen YH; Liu YP; Kuo HF; Hsieh CC; Ding YS; Chen WW; Chong IW
    PLoS One; 2017; 12(7):e0180844. PubMed ID: 28727734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
    Lu YJ; Liu RY; Hu K; Wang Y
    Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-16-1-3p targets TWIST1 to inhibit cell proliferation and invasion in NSCLC.
    Feng QQ; Dong ZQ; Zhou Y; Zhang H; Long C
    Bratisl Lek Listy; 2018; 119(1):60-65. PubMed ID: 29405733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer.
    Lei Z; Xu G; Wang L; Yang H; Liu X; Zhao J; Zhang HT
    FASEB J; 2014 Jun; 28(6):2696-704. PubMed ID: 24558198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-330-3p controls cell proliferation by targeting early growth response 2 in non-small-cell lung cancer.
    Liu X; Shi H; Liu B; Li J; Liu Y; Yu B
    Acta Biochim Biophys Sin (Shanghai); 2015 Jun; 47(6):431-40. PubMed ID: 25935837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-5195-3p plays a suppressive role in cell proliferation, migration and invasion by targeting MYO6 in human non-small cell lung cancer.
    Yang Q
    Biosci Biotechnol Biochem; 2019 Feb; 83(2):212-220. PubMed ID: 30387375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer.
    Zhu X; Gao G; Chu K; Yang X; Ren S; Li Y; Wu H; Huang Y; Zhou C
    Int J Biochem Cell Biol; 2015 Apr; 61():103-14. PubMed ID: 25687035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-455-3p serves as prognostic factor and regulates the proliferation and migration of non-small cell lung cancer through targeting HOXB5.
    Gao X; Zhao H; Diao C; Wang X; Xie Y; Liu Y; Han J; Zhang M
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1074-1080. PubMed ID: 29170127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p/HMGB1/NF-κB pathway.
    Wang Y; Shang G; Wang W; Qiu E; Pei Y; Zhang X
    Life Sci; 2020 Sep; 256():117967. PubMed ID: 32553931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-517a-3p accelerates lung cancer cell proliferation and invasion through inhibiting FOXJ3 expression.
    Jin J; Zhou S; Li C; Xu R; Zu L; You J; Zhang B
    Life Sci; 2014 Jul; 108(1):48-53. PubMed ID: 24846831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2.
    Liu B; Li J; Zheng M; Ge J; Li J; Yu P
    Life Sci; 2017 Nov; 188():87-95. PubMed ID: 28866101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
    Zhou YL; Xu YJ; Qiao CW
    Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
    Yu SH; Zhang CL; Dong FS; Zhang YM
    J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.